New wave of immunotherapy against lung cancer rolls in to clinic

It is my great pleasure to serve as a Guest Editor of this issue of Translational Lung Cancer Research. Here we would like to focus on immunotherapy because new approaches with immunotherapy are rolling in to clinic in the fields of thoracic malignancies such as lung cancer and malignant mesothelioma.